Endogenous Hemin, Formed in the Liver, Eventually Also Appears In
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Carbon Monoxide Down-Regulates Α4β1 Integrin
Chigaev et al. BMC Immunology 2014, 15:52 http://www.biomedcentral.com/1471-2172/15/52 RESEARCH ARTICLE Open Access Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization Alexandre Chigaev1,2,3*, Yelena Smagley1,2,3 and Larry A Sklar1,2,3 Abstract Background: Carbon monoxide (CO), a byproduct of heme degradation, is attracting growing attention from the scientific community. At physiological concentrations, CO plays a role as a signal messenger that regulates a number of physiological processes. CO releasing molecules are under evaluation in preclinical models for the management of inflammation, sepsis, ischemia/reperfusion injury, and organ transplantation. Because of our discovery that nitric oxide signaling actively down-regulates integrin affinity and cell adhesion, and the similarity between nitric oxide and CO-dependent signaling, we studied the effects of CO on integrin signaling and cell adhesion. Results: We used a cell permeable CO releasing molecule (CORM-2) to elevate intracellular CO, and a fluorescent Very Late Antigen-4 (VLA-4, α4β1-integrin)-specific ligand to evaluate the integrin state in real-time on live cells. We show that the binding of the ligand can be rapidly down-modulated in resting cells and after inside-out activation through several Gαi-coupled receptors. Moreover, cell treatment with hemin, a natural source of CO, resulted in comparable VLA-4 ligand dissociation. Inhibition of VLA-4 ligand binding by CO had a dramatic effect on cell-cell interaction in a VLA-4/VCAM-1-dependent cell adhesion system. Conclusions: We conclude that the CO signaling pathway can rapidly down-modulate binding of the VLA-4 -specific ligand. -
Emerging Concepts on the Anti-Inflammatory Actions of Carbon Monoxide-Releasing Molecules (CO-Rms)
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs). Roberto Motterlini, Benjamin Haas, Roberta Foresti To cite this version: Roberto Motterlini, Benjamin Haas, Roberta Foresti. Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs).. Medical Gas Research, BioMed Central, 2012, 2 (1), pp.28. 10.1186/2045-9912-2-28. inserm-00769904 HAL Id: inserm-00769904 https://www.hal.inserm.fr/inserm-00769904 Submitted on 3 Jan 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Motterlini et al. Medical Gas Research 2012, 2:28 http://www.medicalgasresearch.com/content/2/1/28 MEDICAL GAS RESEARCH REVIEW Open Access Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs) Roberto Motterlini*, Benjamin Haas and Roberta Foresti* Abstract Carbon monoxide-releasing molecules (CO-RMs) are a class of organometallo compounds capable of delivering controlled quantities of CO gas to cells and tissues thus exerting a broad spectrum of pharmacological effects. CO-RMs containing transition metal carbonyls were initially implemented to mimic the function of heme oxygenase-1 (HMOX1), a stress inducible defensive protein that degrades heme to CO and biliverdin leading to anti-oxidant and anti-inflammatory actions. -
From99mtc@Citrateand9smtc-Pertechnetateion Netate in Saline Solution and Subsequently Treated with a Sephadex G25 Column
jnin/CONCISE COMMUNICATION BINDING OF 9OmTcION TO HEMOGLOBIN MrinaI Kanti Dewanjee New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts The mechanism and preferential site of bind removed, and the red cells were washed free of ing of 99―'Tcion to hemoglobin had been deter plasma with isotonic saline solution. The cells were mined by the separation of 9@Tc-hemoglobin then incubated with a small volume of oomTc@pertech@ from99mTc@citrateand9smTc-pertechnetateion netate in saline solution and subsequently treated with a Sephadex G25 column. This purified with the content of a kit containing mainly stannous fraction was analyzed by the HC1/acetone mix citrate and glucose. The method of labeling (6) is ture to determine the OsmTc activity distribution described below. with heme and globin. Most of the ssmTc activity Twenty milligrams of SnCl2 were dissolved in 20 is associated with globin fraction. The preferred ml of ACD solution (Abbott). The solution was fit chain for O9mTc ion binding was determined by tered with 0.22-micron Millipore filter paper. A 1-mi the splitting of otmTc.hemoglobin with para aliquot transferred to a serum vial was freeze-dried chloromercuribenzoate solution followed by sep and preserved under nitrogen atmosphere to prevent aration with a diethylaminoethyl cellulose col hydrolysis and oxidation of Sn(II) citrate. The kit umn equilibrated with phosphate buffer. The was reconstituted with I ml of isotonic saline solu @ tsmTc ion, like Cr' ion, tends to bind preferen tion, and the content was transferred to a washed red tially with the beta chain of hemoglobin. -
Download English-US Transcript (PDF)
MITOCW | watch?v=56vQ0S2eAjw SPEAKER 1: The following content is provided under a Creative Commons license. Your support will help MIT OpenCourseWare continue to offer high quality educational resources for free. To make a donation or view additional materials from hundreds of MIT courses, visit MIT OpenCourseWare at ocw.mit.edu. PROFESSOR: Today what I want to do within the lexicon is tell you about nature's most spectacularly beautiful cofactors. And these are formed from vitamin B-12, which you find in your vitamin bottle. OK. So what is the structure of vitamin B-12, and why do I say they are spectacularly beautiful? So it's very hard to see, but if you look at the structure of this, where have you seen a molecule this complicated with five membered rings, each of which has a nitrogen in this? You've seen this when you studied hemoglobin, and you think about heme and proto protoporphyrin IX. If you look at the biosynthetic pathway of heme, a branchpoint of that pathway is to make this ring, which is found in adenosylcobalamin and methylcobalamin, which is what we're going to be focusing on today. And this ring is called the corrin ring. So what I want to do is introduce you a little bit to this corrin ring and what's unusual about it compared to protoporphyrin IX that you've seen before. So the vitamin, as in the case of all vitamins that we've talked about over the course of the semester, is not the actual cofactor used in the enzymatic transformation. -
Binding of Immunoglobulin G to Protoporphyrin IX and Its Derivatives: Evidence the Fab Domain Recognizes the Protoporphyrin Ring
antibodies Article Binding of Immunoglobulin G to Protoporphyrin IX and Its Derivatives: Evidence the Fab Domain Recognizes the Protoporphyrin Ring Koichi Orino Laboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Aomori 034-8628, Japan; [email protected]; Tel.: +81-176-23-3471; Fax: +81-176-23-8703 Received: 15 November 2018; Accepted: 27 December 2018; Published: 4 January 2019 Abstract: Immunoglobulin G (IgG) is known to bind zinc via the Fc domain. In this study, biotinylated protoporphyrin IX (PPIX) was incubated with human IgG and then zinc-immobilized Sepharose beads (Zn-beads) were added to the mixture. After washing the beads, the binding of biotinylated PPIX with IgG trapped on Zn-beads was detected using alkaline phosphatase (ALP)-labeled avidin. Human IgG and its Fab domain coated on microtiter plate wells recognized biotin-labeled PPIX and its derivatives, Fe-PPIX and Zn-PPIX, whereas the Fc domain showed some extent of reaction only with Zn-PPIX. When rabbit anti-bovine transferrin (Tf) antibodies were incubated with biotinylated PPIX, the binding of anti-Tf antibodies with apo-Tf was indirectly detected using ALP-labeled avidin, suggesting that even if the antibody is modified with PPIX, the antibody-antigen reaction occurs. These results suggest that the IgG Fab domain recognizes PPIX and its derivatives, probably via the recognition of the PPIX ring. It is unlikely that binding between the Fab domain and PPIX affects the Fc domain-zinc interaction or antigen-antibody reaction. Keywords: antibody; Fab domain; Fc domain; protoporphyrin; zinc 1. Introduction In 1890, von Behring and Kitasato reported the presence of an agent in the blood that functioned as an anti-toxin, neutralizing diphtheria toxin, and this agent was eventually identified as the antibodies that control infection in body tissues [1,2]. -
Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases
cells Review Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases George J. Kontoghiorghes * and Christina N. Kontoghiorghe Postgraduate Research Institute of Science, Technology, Environment and Medicine, CY-3021 Limassol, Cyprus * Correspondence: [email protected]; Tel./Fax: +357-2627-2076 Received: 7 May 2020; Accepted: 5 June 2020; Published: 12 June 2020 Abstract: Iron is essential for all living organisms. Many iron-containing proteins and metabolic pathways play a key role in almost all cellular and physiological functions. The diversity of the activity and function of iron and its associated pathologies is based on bond formation with adjacent ligands and the overall structure of the iron complex in proteins or with other biomolecules. The control of the metabolic pathways of iron absorption, utilization, recycling and excretion by iron-containing proteins ensures normal biologic and physiological activity. Abnormalities in iron-containing proteins, iron metabolic pathways and also other associated processes can lead to an array of diseases. These include iron deficiency, which affects more than a quarter of the world’s population; hemoglobinopathies, which are the most common of the genetic disorders and idiopathic hemochromatosis. Iron is the most common catalyst of free radical production and oxidative stress which are implicated in tissue damage in most pathologic conditions, cancer initiation and progression, neurodegeneration and many other diseases. The interaction of iron and iron-containing proteins with dietary and xenobiotic molecules, including drugs, may affect iron metabolic and disease processes. Deferiprone, deferoxamine, deferasirox and other chelating drugs can offer therapeutic solutions for most diseases associated with iron metabolism including iron overload and deficiency, neurodegeneration and cancer, the detoxification of xenobiotic metals and most diseases associated with free radical pathology. -
Generate Metabolic Map Poster
Authors: Pallavi Subhraveti Ron Caspi Quang Ong Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_900114035Cyc: Amycolatopsis sacchari DSM 44468 Cellular Overview Connections between pathways are omitted for legibility. -
Definition of the Catalytic Site of Cytochrome C Oxidase: Specific Ligands of Heme a and the Heme A3-CUB Center JAMES P
Proc. Natl. Acad. Sci. USA Vol. 89, pp. 4786-4790, June 1992 Biochemistry Definition of the catalytic site of cytochrome c oxidase: Specific ligands of heme a and the heme a3-CUB center JAMES P. SHAPLEIGH*, JONATHAN P. HOSLERt, MARY M. J. TECKLENBURGO§, YOUNKYOO KIMt, GERALD T. BABCOCKt, ROBERT B. GENNIS*, AND SHELAGH FERGUSON-MILLERt *School of Chemical Sciences, University of Illinois, Urbana, IL 61801; and Departments of tBiochemistry and tChemistry, Michigan State University, East Lansing, MI 48824 Communicated by N. Edward Tolbert, February 6, 1992 (receivedfor review November 17, 1991) ABSTRACT The three-subunit aa3-type cytochrome c ox- and deduced amino acid sequences are very similar to those idase (EC 1.9.3.1) of Rhodobacter sphaeroides is structurally from the closely related bacterium Paracoccus denitrificans and functionally homologous to the more complex mitochon- (2, 10-12). In addition, subunit I shows 50% sequence drial oxidase. The largest subunit, subunit I, is highly con- identity to subunit I ofbovine heart cytochrome c oxidase (9). served and predicted to contain 12 transmembrane segments Hydropathy profile analysis of subunit I from Rb. sphae- that provide all the ligands for three of the four metal centers: roides is consistent with 12 transmembrane helical spans, as heme a, heme a3, and CUB. A variety of spectroscopic tech- previously proposed for bovine subunit I (11). The two- niques identify these ligands as histidines. We have used dimensional model that emerges from this analysis (Fig. 1) site-directed mutagenesis to change all the conserved histidines highlights seven histidine residues, six of which are found to within subunit I of cytochrome c oxidase from Rb. -
Quantum of Effectiveness Evidence in FDA's Approval of Orphan Drugs
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Board National Organization for Rare Disorders One of the key underlying issues facing the development of effective for their intended uses. all drugs, and particularly orphan drugs, is what kind of evi- dence the Food and Drug Administration (FDA) requires for FDA has for many decades acknowledged that there is a need approval. The Federal Food, Drug, and Cosmetic [FD&C] Act for flexibility in applying its standard for approval. For ex- provides that for FDA to grant approval for a new drug, there ample, one of FDA’s regulations states that: “FDA will ap- must be “substantial evidence” of effectiveness derived from prove an application after it determines that the drug meets the “adequate and well-controlled investigations.” This language, statutory standards for safety and effectiveness… While the which dates from 1962, provides leeway for FDA medical re- statutory standards apply to all drugs, the many kinds of drugs viewers to make judgments as to what constitutes “substantial that are subject to the statutory standards and the wide range evidence” of a drug’s effectiveness, that is, of its benefit to of uses for those drugs demand flexibility in applying the stan- patients. dards. Thus FDA is required to exercise its scientific judgment to determine the kind and quantity of data and information an The sole law that applies specifically to orphan drugs, the Or- applicant is required to provide for a particular drug to meet phan Drug Act of 1983, provided financial incentives for drug the statutory standards.” 21 C.F.R. -
Biological Chemistry I, Lexicon
Chemistry 5.07, Fall 2013 Lexicon of biochemical reactions Topic Description Page # # 1 Review of electrophiles and nucleophiles found in Biochemistry 2 2 C-C bond formation via carbonyl chem (aldol and Claisen reactions): Aldehydes, ketones, and Coenzyme 3-5 A and thioesters 3 Prenyl transfer reactions (will not be covered in 5.07) 6 4 Redox cofactors – Flavins (FAD, FMN, riboflavin) and NAD+ (NADP+) 7-12 5 ATP and phosphoryl transfer reactions 13-15 6 Thiamine pyrophosphate 16-18 7 Lipoic acid 19 8 S-Adenosylmethionine (SAM, Adomet), methylations 20 9 Pyridoxal phosphate 21-24 10 Biotin 25 11 Hemes 26-27 12 Metal cofactors: FeS clusters, Cu clusters 28 13 Coenzyme Q 29 14 ET theory 30-32 15 Folates 33-34 16 Methylcobalamin and adenosylcobalamin 35-37 1. Review of electrophiles and nucleophiles in biology Electrophiles Nucleophiles Nucleophilic form H+ Protons + Hydroxyl group Mn+ Metal ions + Sulfhydryl group + Carbonyl carbon Amino group Imine (protonated imine) carbon + Imidazole group (Schiff base) 2 2. Carbonyl Chemistry: Mechanisms of C-C Bond Formation • There are three general ways to form C-C bonds: 1. Aldol reactions where an aldehyde is condensed in a reversible reaction with another aldehyde or a ketone; 2. Claisen reaction in which a Coenzyme A thioester is condensed with an aldehyde or a ketone; 3. Prenyl transfer reactions where two 5 carbon units are condensed to form isoprenoids. • The aldol and claisen reactions involve carbonyl chemistry. These reactions are prevalent in glycolysis, fatty acid biosynthesis and degradation and the pentose phosphate pathway. 1. Aldol reaction generalizations: a. -
Heme Deficiency May Be a Factor in the Mitochondrial and Neuronal Decay of Aging
Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging Hani Atamna*, David W. Killilea, Alison Nisbet Killilea, and Bruce N. Ames* Children’s Hospital Oakland Research Institute, Oakland, CA 94609 Contributed by Bruce N. Ames, September 26, 2002 Heme, a major functional form of iron in the cell, is synthesized in other environmental toxins (15, 16). Ferrochelatase is inacti- the mitochondria by ferrochelatase inserting ferrous iron into vated when its iron-sulfur cluster disassembles because intracel- protoporphyrin IX. Heme deficiency was induced with N-methyl- lular iron levels are low (17) or nitric oxide (NO) is present (18). protoporphyrin IX, a selective inhibitor of ferrochelatase, in two Iron deficiency is by far the most studied; it impairs cognitive human brain cell lines, SHSY5Y (neuroblastoma) and U373 (astro- function in children, impacts the morphology and the physiology cytoma), as well as in rat primary hippocampal neurons. Heme of brain even before changes in hemoglobin appear (19), dam- deficiency in brain cells decreases mitochondrial complex IV, acti- ages mitochondria (20), and causes oxidative stress (20). Iron vates nitric oxide synthase, alters amyloid precursor protein, and deficiency in children is associated with difficulties in performing corrupts iron and zinc homeostasis. The metabolic consequences cognitive tasks and retardation in the development of the CNS resulting from heme deficiency seem similar to dysfunctional (21, 22). Prenatal iron deficiency causes loss of cytochrome c neurons in patients with Alzheimer’s disease. Heme-deficient oxidase (complex IV) in selected regions in the brain of rats (23) SHSY5Y or U373 cells die when induced to differentiate or to and causes a decrease in ferrochelatase (17). -
Structural Basis of Inter-Domain Electron Transfer in Ncb5or, a Redox Enzyme Implicated in Diabetes and Lipid Metabolism
STRUCTURAL BASIS OF INTER-DOMAIN ELECTRON TRANSFER IN NCB5OR, A REDOX ENZYME IMPLICATED IN DIABETES AND LIPID METABOLISM By Bin Deng Submitted to the graduate degree program in Rehabilitation Science and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy Hao Zhu, Ph.D. (co-chair, advisor) Irina Smirnova, Ph.D. (co-chair) David Benson, Ph.D. (co-advisor) WenFang Wang, Ph.D. Aron Fenton, Ph.D. Date defended: August 17, 2011 The Dissertation Committee for Bin Deng certifies that this is the approved version of the following dissertation STRUCTURAL BASIS OF INTER-DOMAIN ELECTRON TRANSFER IN NCB5OR, A REDOX ENZYME IMPLICATED IN DIABETES AND LIPID METABOLISM Hao Zhu, Ph.D. (co-chair, advisor) Irina Smirnova, Ph.D. (co-chair) Date approved: August 22, 2011 ii ABSTRACT NADH cytochrome b5 oxidoreductase (Ncb5or) is a multi-domain redox enzyme found in all animal tissues and associated with the endoplasmic reticulum (ER). Ncb5or contains (from N-terminus to C terminus) a novel N-terminal region, the b5 domain (Ncb5or-b5), the CS domain, and the b5R domain (Ncb5or-b5R). Ncb5or-b5, the heme binding domain, is homologous to microsomal cytochrome b5 (Cyb5A) and belongs to cytochrome b5 superfamily. Ncb5or-b5R, the FAD (flavin adenine dinucleotide) binding domain, is homologous to cytochrome b5 reductase (Cyb5R3) and belongs to ferredoxin NADP+ reductase superfamily. Both superfamilies are of great biological significance whose members have important functions. The CS domain can be assigned into the heat shock protein 20 (HSP20, or p23) family, whose members are known to mediate protein-protein interactions.